J&J Continues Momentum In Second Quarter
Executive Summary
Johnson & Johnson’s medical device sales were up nearly 60% year-over-year in the second quarter of 2021 while Abbott reported 51% growth in its device business, reflecting the recovery in procedure volumes since the worst days of the pandemic in mid-2020.
You may also be interested in...
J&J CEO Gorsky Handing Over The Reins To Vice Chairman Duato
Duato has been involved for the last several years in growing J&J’s pharma and consumer businesses and has led the company’s COVID-19 efforts. Gorsky is stepping down due to a family health issue.
J&J CEO Gorsky Handing Over Reins To Vice Chairman Duato
Joaquin Duato has been involved for the last several years in growing J&J’s pharma and consumer businesses and has led the company’s COVID-19 efforts. Alex Gorsky is stepping down due to a family health issue.
Leveling The Playing Field: Edwards Dedicates $100M To Racial Equity
The fund will support financial institutions in underserved communities and promote an economic cycle focused on creating jobs.